- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05222074
Effect of CVP and IOH on AKI and AKD
January 23, 2022 updated by: HONG LIANG, Nanjing First Hospital, Nanjing Medical University
Venous Congestion Rather Than Intraoperative Hypotension is Associated With Acute Adverse Kidney Events After Cardiac Surgery
This study was aimed to explore the effect of intraoperative venous congestion and intraoperative hypotension (IOH) on acute adverse kidney events, defined as acute kidney injury (AKI) and acute kidney disease (AKD), after cardiac surgery
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Venous congestion and IOH were primary exposures and quantified as area under the curve (AUC) of central venous pressure ≥12, 16 or 20 mmHg or mean arterial pressure ≤55, 65, 75 mmHg.
The primary outcome was AKI or AKD defined as renal dysfunction persisting > 7 days after surgery.
Multivariable logistic regression and Cox proportional hazard models were used to determine the association between intraoperative venous congestion/hypotension and postoperative acute adverse kidney events, respectively, adjusted for relevant confounding factors and multiple comparisons.
Study Type
Observational
Enrollment (Actual)
5127
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jiangsu
-
Nanjing, Jiangsu, China, 210006
- Nanjing First Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 86 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All adults undergoing cardiac surgery between 2016 and 2020 (data analysed in 2021) using electronic health records collected from the Nanjing First Hospital.
Description
Inclusion Criteria:
- Patients aged 18 years and older,
- Patients underwent cardiac surgery (coronary artery bypass grafting, heart valve surgery, heart transplant or surgical excision of intracardiac myxoma)
- Patients receiving invasive intraoperative BP monitoring during surgery
- Patients underwent cardiopulmonary bypass (CPB) during surgery
Exclusion Criteria:
- Pre-existing renal insufficiency defined by presence of abnormal preoperative serum creatinine ≥ 133 μmol/L and/or preoperative diagnosis of renal insufficiency within 6 months'preoperative period.
- Patients with preoperative dialysis dependence within 60 days before the index surgical procedure,
- Surgical duration less than 30 minutes
- Surgery on the aorta
- Insufficient hemodynamic and laboratory data for outcomes and/or exposure ascertainment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
CVP ≥ 12
central venous pressure ≥12 mmHg
|
Venous congestion exposures were quantified as area under the curve (AUC) of central venous pressure ≥12, 16 or 20 mmHg
|
|
CVP ≥ 16
central venous pressure ≥16 mmHg
|
Venous congestion exposures were quantified as area under the curve (AUC) of central venous pressure ≥12, 16 or 20 mmHg
|
|
CVP ≥ 20
central venous pressure ≥20 mmHg
|
Venous congestion exposures were quantified as area under the curve (AUC) of central venous pressure ≥12, 16 or 20 mmHg
|
|
MAP ≤ 55 mmHg
mean arterial pressure ≤55 mmHg
|
Introperation hypotension exposures were quantified as area under the curve (AUC) of mean arterial pressure ≤55, 65, 75 mmHg
|
|
MAP ≤ 65 mmHg
mean arterial pressure ≤65 mmHg
|
Introperation hypotension exposures were quantified as area under the curve (AUC) of mean arterial pressure ≤55, 65, 75 mmHg
|
|
MAP ≤ 75 mmHg
mean arterial pressure ≤75 mmHg
|
Introperation hypotension exposures were quantified as area under the curve (AUC) of mean arterial pressure ≤55, 65, 75 mmHg
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
CSA-AKI
Time Frame: 7 days post operation
|
Cardiovascular surgery associated acute kidney injury.
AKI was defined using the Kidney Disease: Improving Global Outcome (KDIGO) Clinical Practice Guideline for Acute Kidney Injury as an absolute increase in serum creatinine of ≥ 26 μmol/L within 48 hours or an increase in serum creatinine beyond 1.5 times the baseline value within 7 days
|
7 days post operation
|
|
AKD
Time Frame: 8 to 90 days post operation
|
Acute Kidney Disease, which was defined according to the criteria recommended by the Acute Disease Quality Initiative (ADQI) workgroup.4
AKI was quantified within the 7 days' postoperative period, while AKD was defined as serum creatinine value elevated to 1.5 times the baseline value between 8- and 90-day post-operation period.
|
8 to 90 days post operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of AKD of stage 2 and above
Time Frame: 8 to 90 days post operation
|
incidence of AKD of stage 2 and above, defined as increase in serum creatinine beyond 2.0 times the baseline value between 8- and 90-day post-operation period.
|
8 to 90 days post operation
|
|
RRT initiation
Time Frame: from the end of operation to the discharge from hospital, up to 90 days.
|
renal replacement theray (RRT) initiation
|
from the end of operation to the discharge from hospital, up to 90 days.
|
|
value of eGFR
Time Frame: 7 days after operation
|
postoperative estimated glomerular filtration rate (eGFR), which was calculated by MDRD Equation.
|
7 days after operation
|
|
inpatient mortality
Time Frame: 30 days after inhospital
|
mortality during hospital stay
|
30 days after inhospital
|
|
ICU length of stay
Time Frame: from the end of operation to the discharge from ICU, up to 90 days.
|
days stay in ICU
|
from the end of operation to the discharge from ICU, up to 90 days.
|
|
length of hospital stay
Time Frame: from the end of operation to the discharge from hospital, up to 90 days.
|
days stay in hospital
|
from the end of operation to the discharge from hospital, up to 90 days.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Lihai Chen, PhD, chenlihai1983@163.com
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Arora P, Rajagopalam S, Ranjan R, Kolli H, Singh M, Venuto R, Lohr J. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol. 2008 Sep;3(5):1266-73. doi: 10.2215/CJN.05271107. Epub 2008 Jul 30.
- Vervoort D, Swain JD, Pezzella AT, Kpodonu J. Cardiac Surgery in Low- and Middle-Income Countries: A State-of-the-Art Review. Ann Thorac Surg. 2021 Apr;111(4):1394-1400. doi: 10.1016/j.athoracsur.2020.05.181. Epub 2020 Aug 6.
- Weisse AB. Cardiac surgery: a century of progress. Tex Heart Inst J. 2011;38(5):486-90.
- Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017 Nov;13(11):697-711. doi: 10.1038/nrneph.2017.119. Epub 2017 Sep 4.
- Ortega-Loubon C, Fernandez-Molina M, Carrascal-Hinojal Y, Fulquet-Carreras E. Cardiac surgery-associated acute kidney injury. Ann Card Anaesth. 2016 Oct-Dec;19(4):687-698. doi: 10.4103/0971-9784.191578.
- Swaminathan M, Hudson CC, Phillips-Bute BG, Patel UD, Mathew JP, Newman MF, Milano CA, Shaw AD, Stafford-Smith M. Impact of early renal recovery on survival after cardiac surgery-associated acute kidney injury. Ann Thorac Surg. 2010 Apr;89(4):1098-104. doi: 10.1016/j.athoracsur.2009.12.018.
- Robert AM, Kramer RS, Dacey LJ, Charlesworth DC, Leavitt BJ, Helm RE, Hernandez F, Sardella GL, Frumiento C, Likosky DS, Brown JR; Northern New England Cardiovascular Disease Study Group. Cardiac surgery-associated acute kidney injury: a comparison of two consensus criteria. Ann Thorac Surg. 2010 Dec;90(6):1939-43. doi: 10.1016/j.athoracsur.2010.08.018.
- Englberger L, Suri RM, Li Z, Casey ET, Daly RC, Dearani JA, Schaff HV. Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery. Crit Care. 2011;15(1):R16. doi: 10.1186/cc9960. Epub 2011 Jan 13.
- Ouzounian M, Buth KJ, Valeeva L, Morton CC, Hassan A, Ali IS. Impact of preoperative angiotensin-converting enzyme inhibitor use on clinical outcomes after cardiac surgery. Ann Thorac Surg. 2012 Feb;93(2):559-64. doi: 10.1016/j.athoracsur.2011.10.058.
- Welten GM, Chonchol M, Schouten O, Hoeks S, Bax JJ, van Domburg RT, van Sambeek M, Poldermans D. Statin use is associated with early recovery of kidney injury after vascular surgery and improved long-term outcome. Nephrol Dial Transplant. 2008 Dec;23(12):3867-73. doi: 10.1093/ndt/gfn381. Epub 2008 Jul 15.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2016
Primary Completion (Actual)
June 30, 2021
Study Completion (Actual)
August 1, 2021
Study Registration Dates
First Submitted
December 26, 2021
First Submitted That Met QC Criteria
January 23, 2022
First Posted (Actual)
February 3, 2022
Study Record Updates
Last Update Posted (Actual)
February 3, 2022
Last Update Submitted That Met QC Criteria
January 23, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KY20211224-09
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Kidney Injury
-
Instituto Nacional de Cardiologia Ignacio ChavezInstituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranUnknownKidney Injury, Acute | Acute Renal Injury | Acute Kidney Injuries | Kidney Injuries, Acute | Acute Renal InjuriesMexico
-
Yonsei UniversityCompletedAcute Kidney Injury(Postoperative Acute Kidney Injury in Patients Undergoing Aortic Surgery)Korea, Republic of
-
Hospital Civil de GuadalajaraNot yet recruitingAcute Kidney Disease | Acute Kidney Injury (AKI) | Acute Kidney Injuries
-
Sanliurfa Mehmet Akif Inan Education and Research...CompletedIn Acute Kidney InjuryTurkey (Türkiye)
-
University Hospital, GhentWithdrawn
-
Chang Gung Memorial HospitalConmed Pharmaceutical & Bio-Medical CorporationRecruitingAcute Kidney Disease | Acute Kidney Injury (AKI)Taiwan
-
Chinese PLA General HospitalRecruitingPostoperative Acute Kidney InjuryChina
-
Nikola Bradic, MDUnknownAcute Kidney Injury (Nontraumatic)
-
Complexa, Inc.CompletedOpen-Label Safety, Tolerability, PK Study of IV CXA-10 Emulsion in Subjects in Chronic Kidney InjuryAcute Kidney Injury (Nontraumatic)United States
-
South Egypt Cancer InstituteCompletedAcute Kidney Injury (AKI)Egypt
Clinical Trials on Venous congestion
-
Region Örebro CountyRegion Östergötland; Örebro University, Sweden; Dalarna County Council, SwedenNot yet recruitingSepsis | Sepsis and Septic Shock | Sepsis at Intensive Care Unit | Intensive Care Nurses
-
Nanjing First Hospital, Nanjing Medical UniversityCompleted
-
Kanuni Sultan Suleyman Training and Research HospitalRecruiting
-
Third Wave TherapeuticsCompleted
-
University Hospital, LilleCompletedFluid Overload | Fluid Responsiveness | Venous Congestion | Cardiovascular Surgery | Inferior Vena Cava AbnormalityFrance
-
HALEONCompleted
-
E-DA HospitalUnknownTime to Insertion | Rates of ComplicationsTaiwan
-
Hospices Civils de LyonCompleted
-
Milton S. Hershey Medical CenterEnrolling by invitation
-
Assistance Publique - Hôpitaux de ParisTerminated